WO1995024210A1
(en)
*
|
1994-03-08 |
1995-09-14 |
Genetics Institute, Inc. |
Methods and compositions for treatment of periodontal disease and repair of periodontal lesions
|
US5626861A
(en)
*
|
1994-04-01 |
1997-05-06 |
Massachusetts Institute Of Technology |
Polymeric-hydroxyapatite bone composite
|
US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
US6369116B1
(en)
|
1995-06-02 |
2002-04-09 |
Oculex Pharmaceuticals, Inc. |
Composition and method for treating glaucoma
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
US5674292A
(en)
*
|
1995-06-07 |
1997-10-07 |
Stryker Corporation |
Terminally sterilized osteogenic devices and preparation thereof
|
ATE448797T1
(de)
*
|
1996-02-09 |
2009-12-15 |
Amgen Inc |
Zusammensetzung enthaltend il-1ra als interleukin-1 inhibitor und hyaluronan als polymer mit verzögerter wirkstofffreigabe
|
EP0852951A1
(de)
|
1996-11-19 |
1998-07-15 |
Roche Diagnostics GmbH |
Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
|
ZA9711580B
(en)
*
|
1996-12-25 |
1999-09-23 |
Hoechst Marion Roussel Ltd |
Process for the production of purified dimeric bone morphogenetic factors.
|
DE69814352T3
(de)
*
|
1997-02-07 |
2009-08-13 |
Stryker Corp., Kalamazoo |
Matrixlose osteogene vorrichtungen und implantate und verfahren zu deren verwendung
|
AU779278B2
(en)
*
|
1997-02-07 |
2005-01-13 |
Stryker Corporation |
Matrix-free osteogenic devices, implants and methods of use thereof
|
US7041641B2
(en)
*
|
1997-03-20 |
2006-05-09 |
Stryker Corporation |
Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
|
US20010016646A1
(en)
|
1998-03-20 |
2001-08-23 |
David C. Rueger |
Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
|
US6071982A
(en)
*
|
1997-04-18 |
2000-06-06 |
Cambridge Scientific, Inc. |
Bioerodible polymeric semi-interpenetrating network alloys for surgical plates and bone cements, and method for making same
|
AU7260598A
(en)
*
|
1997-04-28 |
1998-11-24 |
Trustees Of The University Of Pennsylvania, The |
Method for promoting myogenesis using osteogenic proteins
|
US6391336B1
(en)
*
|
1997-09-22 |
2002-05-21 |
Royer Biomedical, Inc. |
Inorganic-polymer complexes for the controlled release of compounds including medicinals
|
US6761888B1
(en)
|
2000-05-26 |
2004-07-13 |
Neuralab Limited |
Passive immunization treatment of Alzheimer's disease
|
US7964192B1
(en)
*
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
US7790856B2
(en)
*
|
1998-04-07 |
2010-09-07 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize beta amyloid peptide
|
US7588766B1
(en)
|
2000-05-26 |
2009-09-15 |
Elan Pharma International Limited |
Treatment of amyloidogenic disease
|
TWI239847B
(en)
*
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
US20080050367A1
(en)
*
|
1998-04-07 |
2008-02-28 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
US6787523B1
(en)
*
|
1997-12-02 |
2004-09-07 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
US20050059802A1
(en)
*
|
1998-04-07 |
2005-03-17 |
Neuralab Ltd |
Prevention and treatment of amyloidogenic disease
|
WO2000020021A1
(en)
*
|
1998-10-06 |
2000-04-13 |
Stryker Corporation |
Repair of larynx, trachea, and other fibrocartilaginous tissues
|
DE19906096A1
(de)
|
1999-02-13 |
2000-08-17 |
Walter Sebald |
Protein mit einem Heparin-bindenden Epitop
|
US7371408B1
(en)
|
1999-06-07 |
2008-05-13 |
Wright Medical Technology, Inc. |
Bone graft substitute composition
|
US20090060988A1
(en)
*
|
1999-10-05 |
2009-03-05 |
Kang Ting |
Nell-1 enhanced bone mineralization
|
US7884066B2
(en)
*
|
1999-10-05 |
2011-02-08 |
The Regents Of The University Of California |
NELL-1 enhanced bone mineralization
|
US7687462B2
(en)
*
|
1999-10-05 |
2010-03-30 |
The Regents Of The University Of California |
Composition for promoting cartilage formation or repair comprising a nell gene product and method of treating cartilage-related conditions using such composition
|
US7052856B2
(en)
*
|
1999-10-05 |
2006-05-30 |
The Regents Of The University Of California |
NELL-1 enhanced bone mineralization
|
WO2004024893A2
(en)
*
|
2002-09-13 |
2004-03-25 |
The Regents Of The University Of California |
Nell-1 enhanced bone mineralization
|
EP1155704A1
(en)
*
|
2000-01-13 |
2001-11-21 |
Chih-I Lin |
Orthopedic filling material and method of use thereof
|
US6630153B2
(en)
*
|
2001-02-23 |
2003-10-07 |
Smith & Nephew, Inc. |
Manufacture of bone graft substitutes
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
SE517168C2
(sv)
*
|
2000-07-17 |
2002-04-23 |
Bone Support Ab |
En komposition för ett injicerbart ersättningsmaterial för benmineral
|
US20080233165A1
(en)
*
|
2000-08-07 |
2008-09-25 |
Biolok International, Inc. |
Time release calcium sulfate and growth factor matrix for bone augmentation
|
ES2250504T3
(es)
|
2000-11-29 |
2006-04-16 |
Allergan Inc. |
Prevencion del rechazo de injerto en el ojo.
|
US7700751B2
(en)
|
2000-12-06 |
2010-04-20 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize β-amyloid peptide
|
PE20020574A1
(es)
*
|
2000-12-06 |
2002-07-02 |
Wyeth Corp |
Anticuerpos humanizados que reconocen el peptido amiloideo beta
|
US6949251B2
(en)
*
|
2001-03-02 |
2005-09-27 |
Stryker Corporation |
Porous β-tricalcium phosphate granules for regeneration of bone tissue
|
WO2002083188A2
(en)
*
|
2001-04-16 |
2002-10-24 |
Cassidy James J |
Dense/porous structures for use as bone substitutes
|
US20070254009A1
(en)
*
|
2001-07-13 |
2007-11-01 |
Flow Focusing, Inc. |
Antibiotic/bone morphogenic protein formulation and method of treatment
|
US20060263401A1
(en)
*
|
2001-07-13 |
2006-11-23 |
Flow Focusing, Inc. |
Formulation and Method for Preventing Infection
|
US20070254008A1
(en)
*
|
2001-07-13 |
2007-11-01 |
Flow Focusing, Inc. |
Antibiotic formulation and method of treatment
|
US20050129732A1
(en)
*
|
2001-07-13 |
2005-06-16 |
Flow Focusing, Inc. |
Biodegradable, antibiotic, controlled release tape
|
US7371409B2
(en)
*
|
2001-09-06 |
2008-05-13 |
Wright Medical Technology, Inc. |
Bone graft substitute composition
|
BR0214275A
(pt)
*
|
2001-11-19 |
2004-09-21 |
Scil Technology Gmbh |
Dispositivo tendo propriedades osteocondutora e osteoindutora
|
US7897174B2
(en)
*
|
2002-02-08 |
2011-03-01 |
University Of Erlangen-Nurnberg |
Formulation comprising bioactive agents and method of using same
|
MY139983A
(en)
*
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
WO2003082158A1
(en)
*
|
2002-03-29 |
2003-10-09 |
Wright Medical Technology, Inc. |
Bone graft substitute composition
|
US7291179B2
(en)
*
|
2002-06-24 |
2007-11-06 |
Wright Medical Technology, Inc. |
Bone graft substitute composition
|
US6652887B1
(en)
|
2002-06-24 |
2003-11-25 |
Wright Medical Technology, Inc. |
Bone graft substitute composition
|
US20040002770A1
(en)
*
|
2002-06-28 |
2004-01-01 |
King Richard S. |
Polymer-bioceramic composite for orthopaedic applications and method of manufacture thereof
|
US20040023322A1
(en)
*
|
2002-08-01 |
2004-02-05 |
Goodheart Clyde R. |
Method of producing non-recombinant BMP-2 and use thereof
|
US7029006B2
(en)
*
|
2002-08-29 |
2006-04-18 |
Canon Kabushiki Kaisha |
Sheet feeding apparatus and image forming apparatus
|
US8986737B2
(en)
*
|
2002-09-05 |
2015-03-24 |
Wm. Marsh Rice University |
Antibiotic microspheres for treatment and prevention of osteomyelitis and enhancement of bone regrowth
|
WO2004024199A1
(en)
*
|
2002-09-10 |
2004-03-25 |
Scil Technology Gmbh |
Metal implant coated under reduced oxygen concentration with osteoinductive protein
|
WO2004035762A2
(en)
*
|
2002-10-17 |
2004-04-29 |
Alkermes Controlled Therapeutics, Inc. Ii |
Microencapsulation and sustained release of biologically active polypeptides
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
WO2004069182A2
(en)
*
|
2003-02-01 |
2004-08-19 |
Neuralab Limited |
Active immunization to generate antibodies to soluble a-beta
|
US7507257B2
(en)
*
|
2003-02-04 |
2009-03-24 |
Wright Medical Technology, Inc. |
Injectable resorbable bone graft material, powder for forming same and methods relating thereto for treating bone defects
|
CA2515208A1
(en)
*
|
2003-02-07 |
2004-08-26 |
The Regents Of The University Of California |
Nell peptide expression systems and bone formation activity of nell peptide
|
TWI374893B
(en)
*
|
2003-05-30 |
2012-10-21 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
WO2004112713A2
(en)
*
|
2003-06-20 |
2004-12-29 |
Royer Biomedical, Inc. |
Drug polymer complexes
|
US20040262809A1
(en)
*
|
2003-06-30 |
2004-12-30 |
Smith Todd S. |
Crosslinked polymeric composite for orthopaedic implants
|
DK1677735T3
(da)
|
2003-10-17 |
2014-10-27 |
Joslin Diabetes Center Inc |
Fremgangsmåder og sammensætninger til modulering af adipocytfunktion
|
US20070224278A1
(en)
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
US20060141049A1
(en)
*
|
2003-11-12 |
2006-06-29 |
Allergan, Inc. |
Triamcinolone compositions for intravitreal administration to treat ocular conditions
|
US20050250737A1
(en)
*
|
2003-11-12 |
2005-11-10 |
Allergan, Inc. |
Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
|
US20050101582A1
(en)
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
US8734525B2
(en)
*
|
2003-12-31 |
2014-05-27 |
Warsaw Orthopedic, Inc. |
Osteoinductive demineralized cancellous bone
|
CA2535169A1
(en)
*
|
2003-12-31 |
2005-07-21 |
Osteotech, Inc. |
Improved bone matrix compositions and methods
|
US20070231788A1
(en)
*
|
2003-12-31 |
2007-10-04 |
Keyvan Behnam |
Method for In Vitro Assay of Demineralized Bone Matrix
|
JP2007518804A
(ja)
|
2004-01-20 |
2007-07-12 |
アラーガン、インコーポレイテッド |
トリアムシノロンアセトニドおよびヒアルロン酸を好ましく含有する眼局所治療用組成物
|
US8377904B2
(en)
*
|
2004-02-09 |
2013-02-19 |
Hill's Pet Nutrition, Inc. |
Composition and method for use in cartilage affecting conditions
|
US7691607B2
(en)
*
|
2004-02-09 |
2010-04-06 |
The Regents Of The University Of California |
Expression system of NELL peptide
|
US7456254B2
(en)
*
|
2004-04-15 |
2008-11-25 |
Alkermes, Inc. |
Polymer-based sustained release device
|
EP1734971B8
(en)
|
2004-04-15 |
2012-02-29 |
Alkermes Pharma Ireland Limited |
Polymer-based sustained release device
|
WO2005110374A1
(en)
*
|
2004-04-30 |
2005-11-24 |
Allergan, Inc. |
Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component
|
US20050244471A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
|
US20050244463A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular vasculopathies
|
US20050244478A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Anti-excititoxic sustained release intraocular implants and related methods
|
US8455656B2
(en)
|
2004-04-30 |
2013-06-04 |
Allergan, Inc. |
Kinase inhibitors
|
US7799336B2
(en)
*
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
BRPI0510485A
(pt)
|
2004-04-30 |
2007-11-13 |
Allergan Inc |
implantes inibidores de tirosina cinase intravìtreos biodegradáveis
|
US8425929B2
(en)
*
|
2004-04-30 |
2013-04-23 |
Allergan, Inc. |
Sustained release intraocular implants and methods for preventing retinal dysfunction
|
US20050244458A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular neuropathies
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
US20050244466A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Photodynamic therapy in conjunction with intraocular implants
|
US20050244462A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Devices and methods for treating a mammalian eye
|
US8673341B2
(en)
*
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
US20050244465A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Drug delivery systems and methods for treatment of an eye
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
US7993634B2
(en)
*
|
2004-04-30 |
2011-08-09 |
Allergan, Inc. |
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
|
US8722097B2
(en)
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
US20070059336A1
(en)
*
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
US7771742B2
(en)
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
US8119154B2
(en)
*
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
US8591885B2
(en)
*
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
US8147865B2
(en)
*
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US20050244461A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Controlled release drug delivery systems and methods for treatment of an eye
|
US7384430B2
(en)
*
|
2004-06-30 |
2008-06-10 |
Depuy Products, Inc. |
Low crystalline polymeric material for orthopaedic implants and an associated method
|
EP2216026B1
(en)
*
|
2004-07-12 |
2016-04-20 |
Allergan, Inc. |
Ophthalmic compositions and uses for treating ophthalmic conditions
|
EP1789033B1
(en)
*
|
2004-08-09 |
2019-04-03 |
Enrique Melendez Hevia |
Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders
|
US7250550B2
(en)
*
|
2004-10-22 |
2007-07-31 |
Wright Medical Technology, Inc. |
Synthetic bone substitute material
|
US20060257396A1
(en)
*
|
2004-12-15 |
2006-11-16 |
Jacobsen Jack S |
Abeta antibodies for use in improving cognition
|
AR052051A1
(es)
*
|
2004-12-15 |
2007-02-28 |
Neuralab Ltd |
Anticuerpos ab humanizados usados en mejorar la cognicion
|
US7625560B2
(en)
*
|
2004-12-15 |
2009-12-01 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize beta amyloid peptide
|
US7896921B2
(en)
*
|
2004-12-30 |
2011-03-01 |
Depuy Products, Inc. |
Orthopaedic bearing and method for making the same
|
US7883653B2
(en)
|
2004-12-30 |
2011-02-08 |
Depuy Products, Inc. |
Method of making an implantable orthopaedic bearing
|
US7879275B2
(en)
*
|
2004-12-30 |
2011-02-01 |
Depuy Products, Inc. |
Orthopaedic bearing and method for making the same
|
GT200600031A
(es)
*
|
2005-01-28 |
2006-08-29 |
|
Formulacion anticuerpo anti a beta
|
RU2007124933A
(ru)
*
|
2005-01-28 |
2009-03-10 |
Вайет (Us) |
Стабилизированные жидкие полипептидные составы
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
JP2008530227A
(ja)
*
|
2005-02-16 |
2008-08-07 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
骨状態を治療または予防する薬剤組成物
|
EP1855732A1
(fr)
*
|
2005-02-24 |
2007-11-21 |
Roland Dricot |
Implant osseux
|
US20100150885A1
(en)
*
|
2005-06-01 |
2010-06-17 |
Joslin Diabetes Center, Inc. |
Methods and compositions for inducing brown adipogenesis
|
US20060286171A1
(en)
*
|
2005-06-17 |
2006-12-21 |
Tianhong Zhou |
Bone morphogenetic protein formulations
|
ES2402651T3
(es)
|
2005-09-09 |
2013-05-07 |
Agnovos Healthcare, Llc |
Cemento sustituto de injerto óseo de material compuesto y artículos producidos del mismo
|
US8025903B2
(en)
*
|
2005-09-09 |
2011-09-27 |
Wright Medical Technology, Inc. |
Composite bone graft substitute cement and articles produced therefrom
|
WO2007053850A2
(en)
|
2005-11-01 |
2007-05-10 |
Osteotech, Inc. |
Bone matrix compositions and methods
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
WO2009017467A1
(en)
|
2007-07-27 |
2009-02-05 |
Elan Pharma International Limited |
Treatment of amyloidogenic diseases
|
US8784810B2
(en)
*
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
WO2007136663A2
(en)
*
|
2006-05-16 |
2007-11-29 |
Flow Focusing, Inc. |
Antibiotic/bone morphogenic protein formulation and method of treatment
|
US8802128B2
(en)
*
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
EP2049040B1
(en)
*
|
2006-07-21 |
2015-04-01 |
GENERA ISTRAZIVANJA d.o.o. |
Whole blood-derived coagulum device for treating bone defects
|
JP2009544411A
(ja)
*
|
2006-07-26 |
2009-12-17 |
ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア |
骨形成増進組成物
|
US20080051796A1
(en)
*
|
2006-08-01 |
2008-02-28 |
Warsaw Orthopedic, Inc. |
Graft retention tack
|
ES2398126T3
(es)
|
2006-08-09 |
2013-03-13 |
Intarcia Therapeutics, Inc |
Sistemas de liberación osmótica y unidades de pistón
|
US8969415B2
(en)
|
2006-12-01 |
2015-03-03 |
Allergan, Inc. |
Intraocular drug delivery systems
|
AU2007234612B2
(en)
*
|
2006-12-14 |
2013-06-27 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein stabilization formulations
|
DE102006060958A1
(de)
*
|
2006-12-20 |
2008-06-26 |
Jennissen, Herbert P., Prof. Dr. |
Verfahren zur Herstellung einer Polymermatrix, daraus bestehende Implantate sowie deren Verwendung
|
US20080233199A1
(en)
*
|
2007-03-22 |
2008-09-25 |
Alkermes, Inc. |
Coacervation Process
|
US8003097B2
(en)
*
|
2007-04-18 |
2011-08-23 |
Janssen Alzheimer Immunotherapy |
Treatment of cerebral amyloid angiopathy
|
MX2009011127A
(es)
*
|
2007-04-18 |
2010-03-10 |
Janssen Alzheimer Immunotherap |
Metodo de prevencion y tratamiento de angiopatia amiloide cerebral.
|
US7911053B2
(en)
*
|
2007-04-19 |
2011-03-22 |
Marvell World Trade Ltd. |
Semiconductor packaging with internal wiring bus
|
MX2009011123A
(es)
|
2007-04-23 |
2009-11-02 |
Intarcia Therapeutics Inc |
Formulaciones de suspensiones de peptidos insulinotropicos y sus usos.
|
US8198237B2
(en)
*
|
2007-05-15 |
2012-06-12 |
Stryker Corporation |
Concentrated protein preparations of bone morphogenetic proteins and methods of use thereof
|
US9554920B2
(en)
*
|
2007-06-15 |
2017-01-31 |
Warsaw Orthopedic, Inc. |
Bone matrix compositions having nanoscale textured surfaces
|
AU2008265852B2
(en)
*
|
2007-06-15 |
2014-04-17 |
Warsaw Orthopedic, Inc. |
Method of treating tissue
|
EP2167147B1
(en)
|
2007-06-15 |
2017-03-29 |
Warsaw Orthopedic, Inc. |
Bone matrix compositions and methods
|
US7678764B2
(en)
|
2007-06-29 |
2010-03-16 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein formulations for use at elevated temperatures
|
US20110054408A1
(en)
*
|
2007-07-10 |
2011-03-03 |
Guobao Wei |
Delivery systems, devices, tools, and methods of use
|
WO2009009688A1
(en)
*
|
2007-07-10 |
2009-01-15 |
Osteotech, Inc. |
Delivery system
|
EP2187932B1
(en)
*
|
2007-08-07 |
2015-01-28 |
DePuy Synthes Products, LLC |
Protein formulations comprising gdf-5 in aqueous acidic solution
|
JO3076B1
(ar)
*
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
WO2009052492A2
(en)
|
2007-10-19 |
2009-04-23 |
Osteotech, Inc. |
Demineralized bone matrix compositions and methods
|
DE102007051914A1
(de)
*
|
2007-10-29 |
2009-05-07 |
Herbert Prof. Dr. Jennissen |
Verfahren zur Herstellung von mit Wachstumsfaktoren beladenen Partikeln sowie die so erhaltenen Partikel
|
DK2240155T3
(da)
|
2008-02-13 |
2012-09-17 |
Intarcia Therapeutics Inc |
Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
|
BRPI0911048A2
(pt)
*
|
2008-04-14 |
2015-12-29 |
Atrm Llc |
formulações líquidas tamponadas de gdf-5
|
US9616153B2
(en)
*
|
2008-04-17 |
2017-04-11 |
Warsaw Orthopedic, Inc. |
Rigid bone graft substitute
|
JP2011523357A
(ja)
*
|
2008-05-06 |
2011-08-11 |
ジョスリン ダイアビーティス センター インコーポレイテッド |
褐色脂肪細胞分化を誘導するための方法および組成物
|
US9492375B2
(en)
*
|
2008-07-23 |
2016-11-15 |
Warsaw Orthopedic, Inc. |
Foam carrier for bone grafting
|
US9067981B1
(en)
|
2008-10-30 |
2015-06-30 |
Janssen Sciences Ireland Uc |
Hybrid amyloid-beta antibodies
|
WO2010093950A1
(en)
*
|
2009-02-12 |
2010-08-19 |
Osteotech, Inc. |
Delivery system cartridge
|
WO2010138637A2
(en)
|
2009-05-26 |
2010-12-02 |
The Regents Of The University Of California |
Fibromodulin peptide
|
NZ747990A
(en)
|
2009-09-28 |
2020-06-26 |
Intarcia Therapeutics Inc |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
MX361709B
(es)
|
2009-11-09 |
2018-12-07 |
Allergan Inc |
Composiciones y metodos para estimular el crecimiento del cabello.
|
WO2011086788A1
(ja)
*
|
2010-01-15 |
2011-07-21 |
国立大学法人島根大学 |
骨セメント
|
US9180137B2
(en)
|
2010-02-09 |
2015-11-10 |
Bone Support Ab |
Preparation of bone cement compositions
|
US9358323B2
(en)
*
|
2010-04-29 |
2016-06-07 |
Warsaw Orthopedic, Inc. |
Flowable ceramic putty
|
CA3048850A1
(en)
|
2010-05-11 |
2011-11-17 |
Howmedica Osteonics Corp. |
Organophosphorous, multivalent metal compounds, & polymer adhesive interpenetrating network compositions & methods
|
CN103080301B
(zh)
|
2010-08-19 |
2016-10-19 |
加州大学董事会 |
包含血管周干细胞和nell-1蛋白的组合物
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
RU2633057C2
(ru)
|
2011-04-11 |
2017-10-11 |
Индьюс Байолоджикс Инк. |
Система и способ многофазного высвобождения факторов роста
|
US8765189B2
(en)
|
2011-05-13 |
2014-07-01 |
Howmedica Osteonic Corp. |
Organophosphorous and multivalent metal compound compositions and methods
|
EP2836195B1
(en)
|
2012-04-11 |
2021-03-10 |
Induce Biologics Inc. |
System and method for multiphasic release of growth factors
|
WO2014127243A1
(en)
|
2013-02-15 |
2014-08-21 |
Allergan, Inc. |
Sustained drug delivery implant
|
WO2014128217A1
(en)
|
2013-02-20 |
2014-08-28 |
Bone Support Ab |
Improved setting of hardenable bone substitute
|
TWI651103B
(zh)
|
2013-12-13 |
2019-02-21 |
萊特醫技股份有限公司 |
多相骨移植替代材料
|
RU2682675C2
(ru)
|
2014-03-20 |
2019-03-20 |
Стайбле Терапеутикс Аб |
Композиция для применения при лечении боли, связанной с межпозвоночным диском
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
CN107847638A
(zh)
*
|
2014-12-29 |
2018-03-27 |
佰欧维恩图斯有限责任公司 |
用于骨修复中改善骨诱导性分子递送的系统和方法
|
NZ738102A
(en)
|
2015-06-03 |
2024-02-23 |
Intarcia Therapeutics Inc |
Implant placement and removal systems
|
WO2017075613A1
(en)
|
2015-10-30 |
2017-05-04 |
Bioventus, Llc |
Matrix for enhanced delivery of osteoinductive molecules in bone repair
|
TWI814219B
(zh)
|
2016-05-16 |
2023-09-01 |
美商因塔希亞治療公司 |
升糖素受體選擇性多肽和彼之使用方法
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
CA3026660A1
(en)
|
2016-06-10 |
2017-12-14 |
Bioventus, Llc |
Protein delivery with porous metallic structure
|
US10835580B2
(en)
|
2017-01-03 |
2020-11-17 |
Intarcia Therapeutics, Inc. |
Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
|
US11103618B2
(en)
|
2018-02-22 |
2021-08-31 |
Warsaw Orthopedic, Inc. |
Demineralized bone matrix having improved handling characteristics
|